CIPLA outshines the Industry Growth of 12%

26/07/2016 Financial & Legal Services

Price: Check with seller

No image available


Cipla is one of the finest suppliers of API across the world. The company has made a historic move by reducing the prices of cancer drugs by 50% - 64% in 2012.  CIPLA has outshined the industry growth of 12% with an evoking 20% growth in its domestic business revenue. Get top researched information on Cipla for investing in Cipla Share Price at

More Details

Total Views:5
Reference Id:#888802
Current Rating: /5 0 Vote
Copyright © 2018 |   All Rights Reserved | |   24x7 support |   Email us : info[at]